Product Information
CARVEDILOL ER 10 MG CAPSULE is a generic product labeled by Amneal Pharmaceuticals of New York LLC, priced at $6.5204 per EA under NDC 00115124808. Its NADAC has been published 130 times since Apr 10, 2024.
FDA first approved this application on May 7, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Amneal Pharmaceuticals of New York LLCNDC
00115124808
Classification
Generic
Dosage Form
CAPSULE, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CARVEDILOL PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA204717FDA Approved
5/7/2018
TE Code
AB
On Market Since
1/1/2024
Pharmacological Classes
Price Statistics
The NADAC for CARVEDILOL ER 10 MG CAPSULE has been published 130 times since Apr 10, 2024, and over the history we have for it it has risen 5.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.5204 per EA |
|---|---|
| All-time high | $6.9167 (Apr 15, 2026) |
| All-time low | $4.4193 (May 22, 2024) |
| 52-week high | $6.9167 |
| 52-week low | $5.7008 |
| Median price | $5.8110 |
| Average price | $5.8726 |
| Largest weekly change | -22.0% (Nov 20, 2024) |
| Weeks tracked | 130 |
| Tracking since | Apr 10, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the CARVEDILOL PHOSPHATE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals of New York LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
CARVEDILOL PHOSPHATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
alpha-Adrenergic Blocker class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CARVEDILOL ER 10 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CARVEDILOL ER 10 MG CAPSULE, manufactured by Amneal Pharmaceuticals of New York LLC, is $6.5204 per EA (NDC 00115124808), effective Sep 30, 2026.
How has the price of CARVEDILOL ER 10 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CARVEDILOL ER 10 MG CAPSULE has risen 5.9%. It has been tracked across 130 weekly CMS publications since Apr 10, 2024.
What are the highest and lowest recorded NADAC prices for CARVEDILOL ER 10 MG CAPSULE?
Since Apr 10, 2024, the NADAC for CARVEDILOL ER 10 MG CAPSULE has ranged from a low of $4.4193 (May 22, 2024) to a high of $6.9167 (Apr 15, 2026), with a median of $5.8110 per EA.
Are there cheaper alternatives to CARVEDILOL ER 10 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of CARVEDILOL ER 10 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CARVEDILOL ER 10 MG CAPSULE?
CARVEDILOL ER 10 MG CAPSULE (NDC 00115124808) is labeled by Amneal Pharmaceuticals of New York LLC, and CMS classifies it as a generic product.